 |
Cure Entrepreneurs: New Nonprofit Business Models to Accelerate Research
(L-R): Jana Armstrong, Executive Director, Drugs for Neglected Diseases
initiative, North America; Russell Bromley, COO, Myelin Repair
Foundation; Amy Dockser Marcus, Staff Reporter, The Wall Street Journal;
Susan Kelley, Chief Medical Officer, Multiple Myeloma Research
Foundation; and Steve Perrin, CEO & Chief Scientific Officer, ALS
Therapy Development Institute |
Nonprofit foundations are ideally positioned to make relatively high-risk investments that could significantly move a field of research forward and increase the likelihood that other parties will also invest. What are some of the different strategies foundations are employing to bridge disciplines, institutions, and ideas, and to change the culture and structure of research?
Moderator:
Amy Dockser Marcus, Staff Reporter, The Wall Street Journal
Speakers:
Jana Armstrong, Executive Director, Drugs for Neglected Diseases initiative, North America
Russell Bromley, Chief Operating Officer, Myelin Repair Foundation
George Golumbeski, Senior Vice President, Business Development, Celgene
Susan Kelley, Chief Medical Officer, Multiple Myeloma Research Foundation
Steve Perrin, Chief Executive Officer & Chief Scientific Officer, ALS Therapy Development Institute
Back to Program Schedule and Sessions |
